Janney Montgomery Scott LLC Ligand Pharmaceuticals Inc Transaction History

Janney Montgomery Scott LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 01, 2019	SELL	$128.36 - $272.13 $112,058 - $237,569	-873 Reduced 2.91%	29,168 $3.96 Million
Q3 2018 Nov 05, 2018	SELL	$211.18 - $274.49 $79,192 - $102,933	-375 Reduced 1.23%	30,041 $8.25 Million
Q2 2018 Jul 24, 2018	BUY	$150.77 - $207.98 $477,790 - $659,088	3,169 Added 11.63%	30,416 $6.3 Million
Q1 2018 Apr 19, 2018	SELL	$138.63 - $182.62 $56,838 - $74,874	-410 Reduced 1.48%	27,247 $4.5 Million
Q4 2017 Feb 14, 2018	SELL	$128.36 - $147.04 $86,257 - $98,810	-672 Reduced 2.37%	27,657 $3.79 Million
Q3 2017 Nov 15, 2017	BUY	$120.91 - $137.94 $3.43 Million - $3.91 Million	28,329	28,329 $3.86 Million

277

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.83B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.